BioLife Solutions Inc. stock buy signal for April 2021

High probability seasonal trading setup for BioLife Solutions Inc.(BLFS).
Holding BioLife Solutions Inc.(BLFS) for 46 days from 2021-04-19 to 2021-06-04 for the last 20 years yielded an Average return of 16.34%. over these years, 15 years were positive. Holding BLFS for 46 days each year for the last 20 years yielded a total net profit of 963.48%.

Investment Strategy Simulated Trading Results

Detailed Trades

Entry Date Entry Price Exit Date Exit Price Return
Apr 20, 2020 10.51 Jun 4, 2020 15.85 50.81%
Apr 22, 2019 16.26 Jun 4, 2019 18.74 15.25%
Apr 19, 2018 7.33 Jun 4, 2018 10.37 41.47%
Apr 19, 2017 2.05 Jun 5, 2017 2.16 5.37%
Apr 19, 2016 1.90 Jun 6, 2016 1.60 -15.79%

Additional Information

Profile

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company’s products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. The company markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was founded in 1987 and is headquartered in Bothell, Washington.

Sector: Healthcare
Industry: Medical Instruments & Supplies

Financials

PE Ratio 337.03
PEG Ratio 63.20
Book Value 6.21
Dividend Per Share None
Dividend Yield 0.00
EPS 0.12
Quarterly Earnings Growth YOY 6.40
Quarterly Revenue Growth YOY 0.78
Analyst Target Price 56.25
Trailing PE 337.03
Forward PE 625.00
Price To Sales Ratio TTM 20.44
Price To Book Ratio 5.86
EV To Revenue 23.36
EV To EBITDA 647.00
Beta 1.49
Payout Ratio 0.00
Dividend Date None
Exit Dividend Date None

Earnings

Last earnings
Fiscal Date Ending Reported Date Reported EPS Estimated EPS surprise Surprise Percentage
2020-12-31 2021-03-22 -0.06 -0.02 -0.04 -268.10
2020-09-30 2020-11-05 -0.04 -0.02 -0.02 -154.78
2020-06-30 2020-08-06 -0.70 -0.03 -0.67 -2027.66
2020-03-31 2020-05-14 1.06 -0.03 1.09 3786.46

Price Chart

 

*The Information is provided solely for informational or general educational purposes and should not be construed as an offer to sell or the solicitation of an offer to buy securities or to provide investment advise The opinions and analysis included herein are based on sources believed to be reliable, but no representation or warranty, express or implied is made as to their accuracy, completeness, timeliness, or correctness. All the information contained herein should be verified independently.

Subscribe To Our Newsletter

Stay Up to date and get endless Trading Ideas

Share on facebook
Facebook
Share on twitter
Twitter
Share on whatsapp
WhatsApp
Share on email
Email
Share on telegram
Telegram
Share on print
Print